Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 5
2006 4
2007 3
2008 4
2009 4
2010 4
2012 1
2013 2
2014 3
2015 1
2018 2
2019 1
2020 4
2021 5
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
C-reactive protein and arteriosclerosis.
Torzewski J, Fan J, Schunkert H, Szalai A, Torzewski M. Torzewski J, et al. Mediators Inflamm. 2014;2014:646817. doi: 10.1155/2014/646817. Epub 2014 May 26. Mediators Inflamm. 2014. PMID: 24976688 Free PMC article. No abstract available.
5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique.
Stone GW, Kereiakes DJ, Gori T, Metzger DC, Stein B, Erickson M, Torzewski J, Kabour A, Piegari G, Cavendish J, Bertolet B, Stockelman KA, West NEJ, Ben-Yehuda O, Choi JW, Marx SO, Spertus JA, Ellis SG; ABSORB IV Investigators. Stone GW, et al. Among authors: torzewski j. J Am Coll Cardiol. 2023 Jul 18;82(3):183-195. doi: 10.1016/j.jacc.2023.05.003. Epub 2023 May 17. J Am Coll Cardiol. 2023. PMID: 37207924 Free article. Clinical Trial.
Selective C-Reactive Protein-Apheresis in Patients.
Ries W, Heigl F, Garlichs C, Sheriff A, Torzewski J. Ries W, et al. Among authors: torzewski j. Ther Apher Dial. 2019 Dec;23(6):570-574. doi: 10.1111/1744-9987.12804. Epub 2019 Apr 29. Ther Apher Dial. 2019. PMID: 30924312
C-reactive protein in human atherogenesis: facts and fiction.
Zimmermann O, Li K, Zaczkiewicz M, Graf M, Liu Z, Torzewski J. Zimmermann O, et al. Among authors: torzewski j. Mediators Inflamm. 2014;2014:561428. doi: 10.1155/2014/561428. Epub 2014 Apr 1. Mediators Inflamm. 2014. PMID: 24799767 Free PMC article. Review.
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study.
Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, Escaned J, Iglesias JF, Bennett J, Toth GG, Joner M, Toelg R, Wiemer M, Olivecrano G, Vermeersch P, Garcia-Garcia HM, Waksman R. Haude M, et al. Among authors: torzewski j. EuroIntervention. 2023 Aug 7;19(5):e414-e422. doi: 10.4244/EIJ-D-23-00326. EuroIntervention. 2023. PMID: 37334655 Free article. Clinical Trial.
Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study.
Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, Escaned J, Iglesias JF, Bennett J, Toth G, Joner M, Toelg R, Wiemer M, Olivecrona G, Vermeersch P, Garcia-Garcia HM, Waksman R. Haude M, et al. Among authors: torzewski j. EClinicalMedicine. 2023 Apr 17;59:101940. doi: 10.1016/j.eclinm.2023.101940. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37113674 Free PMC article.
One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry.
Wlodarczak A, Montorsi P, Torzewski J, Bennett J, Starmer G, Buck T, Haude M, Moccetti M, Wiemer M, Lee MK, Verheye S. Wlodarczak A, et al. Among authors: torzewski j. EuroIntervention. 2023 Jun 19;19(3):232-239. doi: 10.4244/EIJ-D-22-01069. EuroIntervention. 2023. PMID: 37226676 Free article.
Temporal changes in coronary plaque as assessed by an artificial intelligence-based optical coherence tomography: from the first-in-human trial on DREAMS 3G scaffold.
Garcia-Garcia HM, Waksman R, Melaku GD, Garg M, Beyene S, Wlodarczak A, Kerai A, Levine MB, van der Schaaf RJ, Torzewski J, Ferdinande B, Escaned J, Iglesias JF, Bennett J, Toth GG, Joner M, Toelg R, Wiemer M, Olivecrona G, Vermeersch P, Haude M. Garcia-Garcia HM, et al. Among authors: torzewski j. Eur Heart J Cardiovasc Imaging. 2024 Mar 27;25(4):491-497. doi: 10.1093/ehjci/jead299. Eur Heart J Cardiovasc Imaging. 2024. PMID: 37936296 Clinical Trial.
50 results